Yikai Luo

机构：Gladstone Institutes, University of California, San Francisco, Tongji Hospital, Huazhong University of Science and Technology · ORCID：0000-0001-7589-7981

发表论文 84 篇 · 总被引 755 次 · h-index 15

代表论文

• Neoadjuvant PARPi or chemotherapy in ovarian cancer informs targeting effector Treg cells for homologous-recombination-deficient tumors (2024 · Cell · 被引 102)
• Artificial Intelligence and Multimodality Data Integration Decipher Tertiary Lymphoid Structure Maturity in Gastric Cancer (2025 · Cancer Research · 被引 9)
• Shadow banking development and corporate green innovation: evidence from A-share listed manufacturing companies in China (2025 · Humanities and Social Sciences Communications · 被引 1)
• Correlation Study Between Neoadjuvant Chemotherapy Response and Long-Term Prognosis in Breast Cancer Based on Deep Learning Models (2025 · Diagnostics · 被引 1)
• Developmental-status-aware transcriptional decomposition establishes a cell state panorama of human cancers (2024 · Genome Medicine · 被引 1)
• In vivo genome-wide CRISPR screens of human T cells in solid tumours (2026 · Nature)